Hydrocortisone 1% W/W Cream
Hydrocortisone 1% W/W Cream, licence 80068875: inactive licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- BIOVANTEK
- NPN or DIN-HM
- 80068875
- Status
- Inactive licence
- Licence date
- 26 April 2016
- Revision date
- 18 May 2022
- Form
- Crème
- Route of administration
- Topique
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| (11bêta)-11,17,21-trihydroxy-prégn-4-ène-3,20-dione Source : Hydrocortisone | 1.0 % (p/p) | Not calculated |
Non-medicinal ingredients
Isoparaffine en C13 à 14, Phénoxyéthanol, Eau purifiée, Poly(propylène glycol), Huile de ricin, Glycérol
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1.0 Crème | 1.0 Tous les jours |
Uses authorised in Canada
For temporary relief of: minor skin irritations associated with redness, itching, dryness and scaling (HC 1985) minor skin irritations, rashes, itching and redness due to eczema, insect bites, poison ivy, poison oak, poison sumac, contact dermatitis (e.g. caused by soaps, detergents, cosmetics and/or jewellery), seborrheic dermatitis, psoriasis (FDA 1986, 1983) (external) feminine, genital itching (FDA 1983) (external) anal itching (due to hemorrhoids) (FDA 1983) Anti-pruritic (FDA 1983) Anti-itch (FDA 1983).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
For external use only. If symptoms worsen or persist more than 7 days, or clear up and occur again within a few days, stop use of this product and do not begin use of any other hydrocortisone product unless directed by a health care practitioner.
- Contre-indications
Do not use in or around the eyes. Do not apply to large areas. Do not use on children 2 years of age or younger, except on the advice of a health care practitioner. Do not use for the treatment of diaper rash, except on the advice of a health care practitioner.
Source
Official Health Canada record, licence 80068875
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2022. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.